Researchers continue to study these effects because heart protection may not come only from weight loss
Clinical trials such as STEP and SURMOUNT report outcomes over months, not weeks, and real-world results depend on adherence, dose, and personal metabolic factors that no program can fully predict
Click on the links below to view the notifications published by the Department of Health & Social Care, plus the guidance document from ABCD & PCDS: Medicine Supply Notification (MSN/2023/061) National Patient Safety Alert: Shortage of GLP-1 receptor agonists Guidance from ABCD & PCDS: GLP-1 RA National Shortage Tell a colleague Share this programme with your colleagues
Thighs: Address stubborn fat deposits in both the inner and outer thigh areas, promoting smoother, more contoured legs
Although meta-analysis (97 comparisons across 95 trials) demonstrated a statistically significant but clinically unimportant increase in FPG [fasting plasma glucose] (Hall et al., 2020), the impact of any diuretic on glucose homeostasis seems to depend on several factors, including the type of diuretic used and the specific metabolic context on which these diuretics are being studied (Grossman et al., 2011)
Schedule your CJC-1295/Ipamorelin consultation with Dr